Acute promyelocytic leukemia (APL) comprises 5–10% of AML cases and is characterized by the presence of a fusion between the transcription factor promyelocytic leukemia (PML) and the retinoic acid receptor α (RARA) genes [19, 20]. Here, RARA is linked to acute promyelocytic leukemia.